Competition Heats Up From New Market Entrants in New Era of Consumer Telehealth

The telehealth boom that was propelled by the COVID-19 pandemic has consolidated at levels lower than at the peak of the pandemic in April 2020, but significantly higher than levels seen before the pandemic. Consumer demand remains strong and will grow over time. McKinsey found that two of five surveyed consumers reported that they will continue to use telehealth going forward. As telehealth goes mainstream, the market represents both opportunities and challenges for traditional video telehealth platform vendors, such as Teladoc, Amwell, and MDLIVE, as well as healthcare providers. Both now face an unprecedented challenge from non-traditional players for control of the patient in terms of how and when they access medical care.

Fueled by unprecedented levels of venture capital investment, new entrants have entered the telehealth market. The competition is not just from competing video telehealth platforms. Some companies are competing for the same service revenue, but with alternative virtual care service models. An example is remote patient monitoring that allows for the transfer of patient data to a remote provider for monitoring and support in the care management of chronic conditions as appropriate.

A 2021 survey of 7,980 US adults conducted by Rock Health and Stanford Center for Digital Health identified the new paradigms disrupting conventional telehealth market parameters as follows:

  • Telehealth as a tool within a comprehensive suite of virtual care offerings to engage patients and providers in managing care and realizing outcomes.
  • Virtual-first care as part of an omnichannel experience that supplements and complements, rather than replaces in-person care across settings.
  • Telehealth for more targeted user segments (e.g., women) and specialized clinical needs (e.g., reproductive health), or both (e.g., adolescent behavioral health).

Although satisfaction among survey respondents is high, retail giants, such as Walmart, CVS, and Amazon, have entered the market, which could see them capture market opportunities that still exist to create value through personalized virtual care experiences and need fulfillment:

  • Walmart’s purchase of multi-specialty telehealth provider MeMD will allow it to provide virtual care services, including urgent care, behavioral health, and primary care to consumers nationwide. Walmart previously partnered with telehealth providers (i.e., Doctor on Demand, 98point6, and Ro) to provide virtual care to its 1.6 million employees in the US. The shift to virtual care is part of Walmart’s larger consumer health strategy, which includes in-store Walmart Health services offering transparent pricing, licensed healthcare staff, and a variety of primary, dental, optometry, and behavioral health care services, and integration with the retail aspect of consumer health and wellness products.
  • After Amazon’s initial foray into telehealth to first serve the needs of its employees, it has expanded its virtual care services as a virtual health service benefit to employers through Amazon Care. In addition to providing in-person primary care visits and prescription delivery at patients’ homes or offices, Amazon Care offers virtual visits via chat or video conference to expand access to primary, preventative, and urgent care 7 days a week, 365 days a year. Available to employees and employers nationwide, Amazon is initially targeting denser metropolitan statistical areas to ensure that individuals using its Amazon Care service have immediate access to in-person care if needed within 60 minutes of their GPS location.
  • Traditional healthcare providers are also under threat from traditional pharmacy retailers, such as CVS Health and Walgreens, which have also been expanding their virtual care services. CVS Health announced a “digital-first, technology-forward” strategy that builds on the decision to pivot the store footprint to focus on advanced primary care centers, enhanced HealthHUB locations, and traditional pharmacy stores. The company’s strategy to deliver omnichannel health services and offerings to meet the needs of 35 million online members when and where they want them will offer significant opportunities to enhance CX, improve efficiencies, and lower costs.

Author Information

Avatar photo

Andrew Broderick is a Senior Analyst contributing to Dash Research’s CX Advisory Service as well as Dash Network’s ongoing editorial coverage of Healthcare CX and Patient Experience. Based in San Francisco, Broderick has more than 20 years’ experience in technology research, analysis, and consulting, including an extensive background in digital health technologies and business practices.

Latest Insights:
How Genesys and AWS Are Redefining AI-Driven Customer Engagement
July 24, 2026
Article
Article

How Genesys and AWS Are Redefining AI-Driven Customer Engagement

Keith Kirkpatrick, Vice President & Research Director, Enterprise Software & Di at Futurum, Genesys Cloud's expanded AWS partnership leverages agentic AI to transform enterprise customer engagement and enable autonomous interactions at scale....
So This Is How AIs Attack- Observations From the OpenAI & Hugging Face Incident
July 24, 2026
Article
Article

So This Is How AIs Attack: Observations From the OpenAI & Hugging Face Incident

Fernando Montenegro and Mitch Ashley, VPs at Futurum, read the OpenAI and Hugging Face agentic incident as a live test of enterprise readiness to detect and contain AI agents that go off-goal...
Nokia Q2 FY 2026 Optical Strength Positions Nokia for the AI Buildout
July 24, 2026
Article
Article

Nokia Q2 FY 2026: Optical Strength Positions Nokia for the AI Buildout

Futurum Research analyzes Nokia’s Q2 FY 2026 earnings, focusing on AI and cloud order strength, optical and IP demand, AI-RAN timing, and supply constraints....
Texas Instruments Q2 FY 2026 Earnings Climb on Broad-based Analog Growth
July 24, 2026
Article
Article

Texas Instruments Q2 FY 2026 Earnings Climb on Broad-based Analog Growth

Brendan Burke, Research Director at Futurum, reviews Texas Instruments' Q2 FY 2026 earnings, the broad industrial recovery, doubling data center revenue, and automotive re-acceleration....
Latest Research:
Redefining Creative Workflows in the AI Era
July 21, 2026

Redefining Creative Workflows in the AI Era

In Redefining Creative Workflows in the AI Era, completed in partnership with Adobe, Futurum Research examines how organizations are moving beyond isolated AI productivity gains toward unified creative platforms that...
The Governance Gap Why Scaling AI Requires More Than Monitoring
July 15, 2026

The Governance Gap: Why Scaling AI Requires More Than Monitoring

In our latest market brieft, The Governance Gap: Why Scaling AI Requires More Than Monitoring, completed in partnership with IBM, Futurum Research examines why AI governance must evolve from periodic...
The Rise of the Super Agent: How Agentic AI Is Reshaping the Enterprise
July 13, 2026
Research
Research

The Rise of the Super Agent: How Agentic AI Is Reshaping the Enterprise

In our latest Market Brief, The Rise of the Super Agent: How Agentic AI Is Reshaping the Enterprise, completed in partnership with Lenovo, Futurum Research examines how autonomous AI systems...

Book a Demo

Welcome

The vision behind everything in Futurum’s Custom Research practice is this: research should show you what is happening, what comes next, and what to do about it. It should be personal to each audience, easy for people to grasp, and structured so LLMs can reason over it accurately. And it should be fast and turnkey; you want answers now, not another project to carry for quarters.

Whether you are defining business, channel, or go-to-market strategy; evaluating vendors or justifying ROI; or commissioning research to fill an emerging market need, we have your back, with a program that answers your questions with the objectivity and credibility to drive real decisions.

To do it, we bring unmatched data to bear: Futurum research, surveys, and market projections; validated market feeds; ETR’s 15 years of insight from 10,000 technology decision-makers; G2’s buyer and user data; and what our analysts hear every day. Add leading primary collection, from AI-moderated voice interviews to surveys and analyst-led interviews, all turnkey, and every project comes out credible, nuanced, and actionable.

And we don’t just drop the results in your lap. For internal work, we provide analyst-led sessions, interactive dashboards, and a range of formats. For market-facing work, Futurum delivers turnkey activation and amplification that actually gets seen, by people and by LLMs, through our media and share of voice. This is research that moves decisions and markets.

We will meet you wherever you are, from a fast-turn brief to a multi-year program, and shape the work to your goals, timeline, and budget. The right program for your moment.

If any of this is useful, I would love to talk.

Benjamin Brown, VP Custom Research, Futurum Research

Benjamin Brown

VP, Custom Research · The Futurum Group

Newsletter Sign-up Form

Get important insights straight to your inbox, receive first looks at eBooks, exclusive event invitations, custom content, and more. We promise not to spam you or sell your name to anyone. You can always unsubscribe at any time.

All fields are required






Thank you, we received your request, a member of our team will be in contact with you.